153 related articles for article (PubMed ID: 18160843)
1. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
2. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
[TBL] [Abstract][Full Text] [Related]
4. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
6. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
7. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
8. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
Won YS; Jeong JS; Kim SJ; Ju MH; Lee SW
Cancer Lett; 2015 Jan; 356(2 Pt B):918-28. PubMed ID: 25444904
[TBL] [Abstract][Full Text] [Related]
9. In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
Lee SJ; Lee SW; Jeong JS; Kim IH
Methods Mol Biol; 2010; 629():307-21. PubMed ID: 20387158
[TBL] [Abstract][Full Text] [Related]
10. Intracellular efficacy of tumor-targeting group I intron-based trans-splicing ribozyme.
Kwon BS; Jeong JS; Won YS; Lee CH; Yoon KS; Hyung Jung M; Kim IH; Lee SW
J Gene Med; 2011 Feb; 13(2):89-100. PubMed ID: 21322101
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase].
Qu Y; Liu SQ; Peng WZ; Liu BL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Liu D; Chi HM; Cai Q
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):200-5. PubMed ID: 16490880
[TBL] [Abstract][Full Text] [Related]
13. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of endogenous mRNA expression in a mouse tumor model by adenovirus harboring trans-splicing ribozyme.
Hong SH; Jeong JS; Lee YJ; Jung HI; Kim KT; Kim YH; Lee YS; Lee SW; Bae CD; Park J; Kim IH
FEBS Lett; 2007 Nov; 581(28):5396-400. PubMed ID: 17976379
[TBL] [Abstract][Full Text] [Related]
15. Cancer-specific induction of adenoviral E1A expression by group I intron-based trans-splicing ribozyme.
Won YS; Lee SW
J Microbiol Biotechnol; 2012 Mar; 22(3):431-5. PubMed ID: 22450801
[TBL] [Abstract][Full Text] [Related]
16. Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme.
Won YS; Lee SW
J Biotechnol; 2012 Mar; 158(1-2):44-9. PubMed ID: 22285955
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron.
Jung HS; Kwon BS; Lee SW
Biotechnol Lett; 2005 Apr; 27(8):567-74. PubMed ID: 15973491
[TBL] [Abstract][Full Text] [Related]
18. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
Qu Y; Liu S; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
[TBL] [Abstract][Full Text] [Related]
19. Small Animal PET Imaging of hTERT RNA-Targeted HSV1-tk Gene Expression with
Seo MJ; Park JH; Lee KC; Lee YJ; Lee TS; Choi TH; Lee SW; Kim KI; Kang JH
Cancer Biother Radiopharm; 2020 Feb; 35(1):26-32. PubMed ID: 31746630
[No Abstract] [Full Text] [Related]
20. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
